IBD
An Australian charity has recently opened up its wealth of IBD data for IBD R&D worldwide.
Berlin startup targets irritable bowel syndrome and other gastrointestinal problems with a digital therapy program.
The collaboration will use AI technology to accelerate the drug discovery process.
The firms are collaborating to launch a digital medication management and lifestyle platform across Europe.
Zemedy is an app targeted at treating irritable bowel syndrome symptoms through a combination of CBT, hypnotherapy exercises and stress management techniques.
The startup said that the seed funding will support continued development of Regulora, its behavioral intervention delivered through a mobile platform.